BTIG raised the firm’s price target on MoonLake Immunotherapeutics (MLTX) to $81 from $71 and keeps a Buy rating on the shares. The firm ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from Buy to Neutral. Analyst Price Forecast Suggests 22.11% Upside As of December 23, 2024, ...

On Wednesday, Nuvation Bio Inc (NUVB) stock saw a decline, ending the day at $3.01 which represents a decrease of $-0.24 or -7.38% from the prior close of $3.25. The stock opened at $3.32 and touched ...

Vuzix Corp (VUZI) stock saw a modest uptick, ending the day at $4.22 which represents a slight increase of $0.11 or 2.68% from the prior close of $4.11. The stock opened at $4.08 and touched a low of ...

“In 2025, the energy sector will be less about barrels of oil and more about...billions of cubic feet of natural gas demand ...

Carisma Therapeutics, Inc. (NASDAQ:CARM – Get Free Report) has earned an average recommendation of “Hold” from the seven ...

International Assets Investment Management LLC lowered its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 95.3 ...

StockNews.com upgraded shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) from a buy rating to a strong-buy rating in a research note published on Wednesday. A number of other equities ...

KeyBanc analyst Justin Patterson maintained a Buy rating on DoorDash (DASH – Research Report) today and set a price target of $225.00. The ...